Lee Ainslie’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-44,521
Closed -$435K 323
2024
Q2
$435K Sell
44,521
-12,506
-22% -$153K 0.01% 254
2024
Q1
$861K Sell
57,027
-15,897
-22% -$288K 0.02% 144
2023
Q4
$1.57M Buy
72,924
+14,934
+26% +$276K 0.03% 93
2023
Q3
$1.08M Sell
57,990
-110,814
-66% -$2.59M 0.02% 119
2023
Q2
$4.27M Buy
168,804
+103,257
+158% +$2.6M 0.09% 63
2023
Q1
$1.7M Buy
65,547
+53,571
+447% +$1.43M 0.04% 95
2022
Q4
$283K Buy
+11,976
New +$323K 0.01% 304
2021
Q1
Sell
-260
Closed -$52K 862
2020
Q4
$52K Buy
+260
New +$52.9K ﹤0.01% 621
2020
Q3
Sell
-1,090
Closed -$208K 702
2020
Q2
$208K Buy
+1,090
New +$191K ﹤0.01% 511

Other funds holding TDOC

Lee Ainslie's TDOC Position: Q3 2024 in Review

Lee Ainslie sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 44,521 shares — an estimated $435K sold.

Lee Ainslie first reported a position in TDOC in Q2 2020 and held it in 9 quarters. The position peaked at $4.27M in Q2 2023. 366 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • Lee Ainslie reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
  • Lee Ainslie sold 44,521 Teladoc Health shares in Q3 2024, an estimated $435K.
  • Lee Ainslie first reported a position in Teladoc Health in Q2 2020 and held it in 9 quarters.
  • Lee Ainslie's Teladoc Health position peaked at $4.27M in Q2 2023.
  • 366 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on Maverick Capital's 13F filing for Q3 2024, filed 14 Nov 2024.